Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials
By Jeffrey S. Berger, M. Roncaglioni, F. Avanzini, I. Pangrazzi, G. Tognoni, David L. Brown. Journal of the American Medical Association (JAMA), 2006
4,039 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/7ed950f7f2422bfba345cbea3ca3fe94d93846d6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- N. Colombo
- Torsten O. Nielsen
- Mitchell Dowsett
- Jack Cuzick
- P. Konstantinopoulos
- A. Bois
- C. Sessa
- Lisa M. McShane
Citations in the corpus
- Cancer health disparities in racial/ethnic minorities in the United States (2020, background): “1).(218) Other aspects of smoking behaviour might partially explain the differences in lung cancer incidence: very light (1–5 cigarettes per day) daily smokers or non-daily smoking among Hispanics/ Latinos,(222) smoking topography (puff volume, duration, flow, etc.”
- Factors Influencing the Decline in Stroke Mortality (2013, background): “69) in the study sample.(296) However, the largest randomized, controlled trial in women found a nonsignificant increase in fatal stroke (OR, 1.”
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (2011, result): “In each study, the difference in the degree of Ki67 suppression between the study arms mirrored the difference in recurrence in equivalent large adjuvant trials, Arimidex, Tamoxifen Alone or Combined (ATAC) trial and Breast International Group (BIG) 1-98 trial, respectively (18,19).”
- Homologous recombination deficiency: Exploiting the fundamental vulnerability of ovarian cancer (2015, background): “The only dose-intensity approach that has been associated with improved survival was administration of chemotherapy via the intraperitoneal route, which is capable of achieving high local concentrations of chemotherapy with acceptable systemic side effects (10).”